0001161697-21-000393.txt : 20210819
0001161697-21-000393.hdr.sgml : 20210819
20210819170754
ACCESSION NUMBER: 0001161697-21-000393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210817
FILED AS OF DATE: 20210819
DATE AS OF CHANGE: 20210819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANDE ALICIA
CENTRAL INDEX KEY: 0001402652
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 211190986
MAIL ADDRESS:
STREET 1: 220 MIRACLE MILE
STREET 2: SUITE 234
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 08-17-2021
X0306
4
2021-08-17
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001402652
GRANDE ALICIA
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
VP, Treasurer and CFO
Common stock, par value $0.001 per share
2021-08-17
4
M
0
100000
3.12
A
507441
D
Common stock, par value $0.001 per share
2021-08-17
4
S
0
100000
5.669
D
407441
D
Common stock, par value $0.001 per share
2021-08-18
4
M
0
70000
3.12
A
477441
D
Common stock, par value $0.001 per share
2021-08-18
4
S
0
13000
5.683
D
464441
D
Options to purchase common stock
3.12
2021-08-17
4
M
0
100000
0
D
2021-08-28
Common Stock
100000
1391334
D
Options to purchase common stock
3.12
2021-08-18
4
M
0
70000
0
D
2021-08-28
Common Stock
70000
1321334
D
Shares were sold in various lots from $5.62 to $5.725 per share. The listed sale price represents a weighted
average price for the shares sold.
Shares were sold in various lots from $5.65 to $5.785 per share. The listed sale price represents a weighted average price for the shares sold.
Shares were sold to cover exercise price of options and tax withholding requirements.
Options vested in three annual tranches beginning on August 28, 2015.
/s/ Alicia Grande
2021-08-19